KIVALITA CONSULTING

Biweekly News about Life Science Market 02/02/2021

Article image
Compartilhe

In four decades, Brazil reduces from 55% to 5% production capacity of pharmaceutical inputs

In four decades, Brazil reduces from 55% to 5% production capacity of pharmaceutical inputs In the 1980s, Brazil produced 55% of the pharmaceutical inputs consumed in the country. Today, this percentage has dropped to 5%, according to data from Abiquifi (Brazilian Association of the Pharmaceutical Inputindustry).

 

HPPC sector trade balance has a surplus of US$ 23.4 million in 2020

HPPC sector trade balance has a surplus of US$ 23.4 million in 2020 The trade balance of the Brazilian sector of personal hygiene, perfumery and cosmetics recorded a surplus of US$ 23.4 million in 2020, reversing the deficit value recorded in 2019, of US$ -105.9 million. The data were released by the Ministry of Economy.

 

Natura & Co becomes the world's largest B Company 

Natura & Co becomes the world's largest B Company B Companies meet the highest standards of social and environmental performance verification, public transparency and legal responsibility when reconciling profit and purpose. Natura, The Body Shop and Aesop have already received the seal, while Avon certification is scheduled for 2025.

 

5 technological advances that will transform the supply chain of the pharmaceutical sector 

5 technological advances that will transform the supply chain of the pharmaceutical sector The volume of vaccines for covid-19, which are expected to be distributed in the near future, will be unprecedented. Supply chains in the pharmaceutical sector will be widely expanded so that such products can reach their destination quickly and safely.

 

Sign up for our Fortnightly newsletter and be the first to know!

    Endereço
  • Rua dos Três Irmãos, 310 - Sala 302 - Vila Progredior
    São Paulo - SP
© 2020 Kivalita Consulting | Todos os direitos reservados